
Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster, more reliable trial outcomes through harmonized data practices.
To address this shift, providers are integrating AI, generative AI, and automation throughout the CDM lifecycle, enhancing efficiency in data ingestion, validation, medical coding, and protocol design. These advances, coupled with global delivery capabilities and deep therapeutic expertise, are empowering enterprises to scale operations and navigate patient-centric trials’ demands. In response to evolving market needs, providers are also expanding their portfolios to offer comprehensive, end-to-end solutions across the CDM value chain.
-
Clinical Data Management (CDM) Operations PEAK Matrix® Assessment 2025
In this report, Everest Group comprehensively evaluates 22 leading providers featured in the Clinical Data Management Operations PEAK Matrix® report. It highlights each provider’s service focus, key IP/solutions, domain-specific investments, and case studies.
Scope
- Industry: life sciences
- Geography: global
- This assessment is based on Everest Group’s annual RFI process for the calendar year 2025, interactions with clinical data management providers, client reference checks, and an ongoing analysis of the clinical data management market
Contents
This report analyzes 22 life sciences CDM providers and includes:
- Their relative positioning on the Everest Clinical Data Management Operations PEAK Matrix®
- A comparison of their capabilities and market shares
- Their strengths and limitations
READ ON
What is the PEAK Matrix®?
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.